Trump says pharma tariffs could eventually reach up to 250%
U.S. President Donald Trump talks to members of the press at Lehigh Valley International Airport in Allentown, Pennsylvania, U.S., August
Read More
Biotechnology
Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow
The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on
Read More
Is the post-earnings rally in this struggling life sciences stock for real this time?
The upward wave in shares of Danaher since the life sciences company reported second-quarter earnings has left patient investors wondering
Read More
UnitedHealth says it is cooperating with DOJ investigations into Medicare billing practices
UnitedHealth Group revealed Thursday it is facing Department of Justice investigations over its Medicare billing practices, adding to a string
Read More
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
Bristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients
Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk’s patent on its branded
Read More
Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination
The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on
Read More
RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt |
Read More
FDA outlines stricter Covid vaccine booster approval standards for healthy people
Brandon Guerrero, of Compton, California, is given both a flu and Covid vaccine at CVS in Huntington Park, California, Aug.
Read More
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023.
Read More